Aquiline Capital-backed Aspirion completed the merger with ARx.

Aquiline Capital-backed Aspirion, a technology-enabled revenue cycle management healthcare company, completed the merger with ARx, a revenue cycle management company dedicated to improving revenue cycle management financial performance for healthcare providers. Financial terms were not disclosed. "Today’s announcement illustrates Aspirion’s commitment to broadening our support of US hospital systems’ most difficult reimbursements and our execution against our goal of continually expanding our capabilities and reach in this vertical. What most impressed us with ARx was how their clients spoke of the support they received. It was clear that we share very similar values, and they consistently deliver a premium level of service which is so core to all we do. ARx’s obsession with providing an experience that clients couldn’t find elsewhere and complementary offerings makes this deal align with our strategy," Jason Erdell, Aspirion CEO.